ArticleFrontiers in medicine2025

Dupilumab treatment is not associated with changes in lymphoma risk in atopic dermatitis and other type 2 inflammatory diseases: data from a large-scale retrospective cohort study.

Khalaf Kridin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.